BLAC: Bellevue Life Sciences Acquisition Corp. Stock

by  •  • Comments Off on BLAC: Bellevue Life Sciences Acquisition Corp. Stock

SIC 3841 – Surgical and Medical Instruments and Apparatus

Valuation
Market Cap ($M) 60.22
Enterprise Value ($M) 60.28
Book Value ($M) -3.91
Book Value / Share -0.69
Price / Book -15.41
NCAV ($M) -40.51
NCAV / Share -7.20
Price / NCAV -1.49

Profitability (mra)
Return on Invested Capital (ROIC) n/a
Return on Assets (ROA) 0.01
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 0.01
Current Ratio 0.01

Balance Sheet (mrq) ($M)
Current Assets 0.02
Assets 36.63
Liabilities 40.53
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -1.83
Net Income 0.40

Cash Flow Statement (mra) ($M)
Cash From Operations -0.82
Cash from Investing -33.83
Cash from Financing 34.54

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-08 13G Bellevue Global Life Science Investors LLC 36.20
02-05 13G/A Space Summit Capital LLC 0.00 -100.00

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2023-11-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q
2023-08-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q
2023-05-22 10-Q UNITED STATES

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-26 7,012 88,879 7.89
2024-04-25 600 6,121 9.80
2024-04-24 3,000 2,700 111.11

(click for more detail)

Similar Companies
BEAT – HeartBeam, Inc. BIOL – BIOLASE, Inc.
BJDX – Bluejay Diagnostics, Inc. BLFS – BioLife Solutions, Inc.
BRSH – Bruush Oral Care Inc.


Financial data and stock pages provided by
Fintel.io